Artisan Partners Limited Partnership Invests $22.78 Million in Integer Holdings Co. (NYSE:ITGR)

Artisan Partners Limited Partnership acquired a new stake in Integer Holdings Co. (NYSE:ITGR) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 171,864 shares of the medical equipment provider’s stock, valued at approximately $22,775,000. Artisan Partners Limited Partnership owned about 0.51% of Integer as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Geode Capital Management LLC grew its position in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after acquiring an additional 9,421 shares in the last quarter. Congress Asset Management Co. boosted its holdings in Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock worth $66,041,000 after purchasing an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Integer by 1.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider’s stock valued at $54,146,000 after purchasing an additional 4,559 shares during the last quarter. Lord Abbett & CO. LLC raised its holdings in shares of Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after purchasing an additional 9,754 shares during the period. Finally, Tributary Capital Management LLC lifted its position in shares of Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock worth $38,103,000 after buying an additional 2,289 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

ITGR stock opened at $117.09 on Friday. The company has a market capitalization of $3.94 billion, a P/E ratio of 34.85, a PEG ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The company has a 50-day simple moving average of $130.47 and a 200 day simple moving average of $131.97. Integer Holdings Co. has a fifty-two week low of $107.11 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Sell-side analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Raymond James initiated coverage on Integer in a research note on Friday. They set an “outperform” rating and a $145.00 price objective for the company. KeyCorp raised their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Benchmark upped their price target on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Integer presently has a consensus rating of “Moderate Buy” and a consensus target price of $148.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.